[Treatment of headaches in general practice. A therapeutic study (author's transl)].
A therapeutic study was conducted by practitioners working in a group practice, to evaluate the activity of tiapride in treating headaches, over a period of 1 year. The results were satisfactory in 60.6% of cases, especially in patients with headaches of psychogenic or digestive origin. The dosage was 150 to 200 mg orally, and the product was well tolerated apart from somnolence which was noted in about 1 case out of 4.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D001549:Benzamides / Q000627:therapeutic use*; D004066:Digestive System Diseases / Q000150:complications; D005260:Female; D006261:Headache / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000150:complications; D013976:Tiapamil Hydrochloride / Q000008:administration & dosage / Q000627:therapeutic use*
D001549:Benzamides; D013976:Tiapamil Hydrochloride
Essai thérapeutique dans les céphalées en ambulatoire.